A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer
[Protocol 06-103] |
Janjigian, Yelena |
|
A Phase III Study of Radiation Therapy with and without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
[Protocol 11-120] |
Kaley, Thomas |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
Early Onset and Familial Gastric Cancer Registry
[Protocol 05-118] |
Kelsen, David |
- Hereditary Cancer & Genetics
- Upper Gastrointestinal
|
A Phase II Study of Hepatic Arterial Infusion and Intravenous Chemotherapy with or without Panitumumab in Patients with Normal KRAS with Resected Liver Metastases from Colorectal Cancer
[Protocol 10-137] |
Kemeny, Nancy |
|
A Phase II Study of Sunitinib or Cediranib for Inoperable Metastatic Alveolar Soft Part Sarcoma
[Protocol 12-095] |
Keohan, Mary |
|
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation
[Protocol 11-038] |
Kernan, Nancy |
- Leukemia
- Acute Lymphoblastic Leukemia
|
Defibrotide for Patients with Hepatic Veno-Occlusive Disease
[Protocol 08-060] |
Kernan, Nancy |
- Blood and Marrow Transplantation
|
A Survey of Psychosocial Needs and Exploration of Online Support for Patients with Pleural Mesothelioma
[Protocol 11-066] |
Key, Richard |
|
A Phase II Study of Sunitinib to Treat High-Grade Glioma and Ependymoma Tumors in Pediatric and Young Adult Patients
[Protocol 13-026] |
Khakoo, Yasmin |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
A Phase III Study of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
[Protocol 11-190] |
King, Tari |
|
A Phase IIB Study of 5-Azacitidine with or without Panobinostat in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
[Protocol 12-219] |
Klimek, Virginia |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
|
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128] |
Klimek, Virginia |
|
A Phase III Study of Cytarabine with or without Vosaroxin in Patients with First Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 11-094] |
Klimek, Virginia |
- Leukemia
- Acute Myelogenous Leukemia
|
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
[Protocol 12-114] |
Kobos, Rachel |
|
Treatment for Very Low-Risk and Standard-Risk Favorable Histology Wilms Tumor
[Protocol 12-084] |
Kobos, Rachel |
|
A Phase II Study of New Treatment Approaches for High-Risk Renal Tumors
[Protocol 12-026] |
Kobos, Rachel |
|
Renal Tumor Classification, Biology, and Banking Study
[Protocol 12-014] |
Kobos, Rachel |
|
Treatment of Children with All Stages of Hepatoblastoma
[Protocol 10-046] |
Kobos, Rachel |
|
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-175] |
Koehne, Guenther |
|
A Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051] |
Koehne, Guenther |
- Blood & Marrow Stem Cell Transplantation
- Sibling and Unrelated Volunteer
- Hematology
|
